Related Experiment Video
Updated: Jan 17, 2026

The Drosophila Imaginal Disc Tumor Model: Visualization and Quantification of Gene Expression and Tumor Invasiveness Using Genetic Mosaics
Published on: October 6, 2016
Novel modifiers of oncoprotein-mediated Polycomb inhibition in Drosophila melanogaster
Samuel D Krabbenhoft1, Tyler E Masuda1, Yadwinder Kaur1
1Department of Biomolecular Chemistry, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, 440 Henry Mall, Madison, WI 53706, United States.
Abstract:
Polycomb Repressive Complex 2 (PRC2) maintains epigenetic repression through the catalysis of H3K27 trimethylation (H3K27me3), which restricts gene expression and preserves developmental gene-regulatory networks. The integrity of PRC2-mediated gene silencing depends critically on the ability of PRC2 to establish and propagate H3K27me3 beyond initial recruitment sites. The oncoproteins EZHIP and histone H3 K27M specifically inhibit this propagation by blocking the allosterically activated state of PRC2, leading to global disruption of H3K27me3 patterns and developmental abnormalities. To uncover chromatin-related pathways intersecting with PRC2 repression, we developed a Drosophila melanogaster model with tissue-specific expression of EZHIP and H3 K27M. A targeted RNAi screen of conserved chromatin regulators identified genetic modifiers that when knocked down either enhanced or suppressed developmental phenotypes driven by these PRC2 inhibitors. Strong suppressors, including the Trithorax group proteins Ash1 and Trx, the PR-DUB complex member Asx, and the nucleoporin Nup153, restored normal development despite persistent depletion of global H3K27me3. Gene expression analyses revealed that suppression reflected reduced expression of genes aberrantly activated following PRC2 inhibition. Together, these findings highlight conserved chromatin-regulatory pathways that intersect with Polycomb to maintain transcriptional balance and support developmental homeostasis.
Insights
Polycomb Repressive Complex 2 (PRC2) inhibitors like EZHIP disrupt gene silencing. Conserved chromatin regulators, identified in a Drosophila model, can suppress these developmental defects by restoring transcriptional balance.
Area of Science:
- Epigenetics
- Developmental Biology
- Chromatin Regulation
Background:
- Polycomb Repressive Complex 2 (PRC2) establishes epigenetic repression via H3K27me3, crucial for developmental gene regulation.
- PRC2's ability to propagate H3K27me3 is vital for sustained gene silencing.
- Oncoproteins EZHIP and H3 K27M disrupt H3K27me3 propagation, causing developmental abnormalities.
Purpose of the Study:
- To identify chromatin regulators that modify developmental phenotypes caused by PRC2 inhibitors.
- To understand how chromatin pathways intersect with PRC2-mediated repression.
Main Methods:
- Development of a Drosophila melanogaster model for studying EZHIP and H3 K27M.
- Tissue-specific expression of PRC2 inhibitors.
- Targeted RNAi screen of conserved chromatin regulators.
- Gene expression analysis.
Main Results:
- Identified genetic modifiers that suppress developmental defects induced by EZHIP and H3 K27M.
- Strong suppressors include Trithorax group proteins (Ash1, Trx), PR-DUB complex (Asx), and Nup153.
- Suppression correlated with reduced expression of aberrantly activated genes.
Conclusions:
- Conserved chromatin pathways modulate PRC2 function and developmental homeostasis.
- Targeting these pathways may offer therapeutic strategies for developmental disorders linked to PRC2 dysfunction.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Inhibition of Cdk Activity
Induced Pluripotent Stem Cells
Somatic...
Epigenetic Regulation
X-chromosome...
Position-effect Variegation
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...

